JRC scientists estimate current and future amounts of increasing amounts of diverse wastes, and explore ways to make them part of the circular economy.
It contains twelve pollutants, the impacts of which have been identified as having the possibility for widespread concern for the environment and human health.
It contains twelve pollutants, the impacts of which have been identified as having the possibility for widespread concern for the environment and human health.
Global warming is bringing the world closer to crossing tipping points, setting a path to events that could permanently alter how the planet works, within years, decades or centuries.
Installing decentralised solar photovoltaic systems in African schools can help improve education, boost economic development and decrease CO2 emissions.
Climate change is reducing the flows of rivers into the Mediterranean. This could in turn devastate marine life and inflict significant losses in the fishery sector.
If current disease prevalence remains constant, doctor and nurse numbers would need to grow by 30% and 33% respectively by 2071 to meet demand of ageing population.
Help spot various signals of change – from the most surprising to the most futuristic – and make sure that policymakers are aware of emerging trends for a resilient future
EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 13:30 (CET) to 14 March 2025, 12:30 (CET)
Clinical Trials Information System (CTIS): Walk-in clinic - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 16:00 (CET) to 20 November 2024, 17:00 (CET)
LinkedIn Live session: Improving efficiency of approval process for new medicines in the EU , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 December 2024, 12:30 (CET) to 5 December 2024, 13:30 (CET)
Pharmacovigilance Risk Assessment Committee (PRAC): 25 - 28 November 2024, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024 to 28 November 2024
European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of centrally authorised products (CAPs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)
Translating innovation into access for ATMPs: third EU-Innovation network multi-stakeholder meeting, Online, Rome, Italy, Broadcast, from 15 November 2024, 09:00 (CET) to 15 November 2024, 17:00 (CET)
UPD refresher webinar for marketing authorisation holders on volume of sales submission, Online, from 5 December 2024, 10:00 (CET) to 5 December 2024, 11:00 (CET)
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - February 2025, Online, from 10 February 2025, 09:00 (CET) to 12 February 2025, 13:30 (CET)
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - April 2025, Online, from 9 April 2025, 14:00 (CEST) to 11 April 2025, 18:30 (CEST)
Eleventh Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 09:30 (CET) to 21 November 2024, 13:00 (CET)
Public event: advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
Biannual Big Data Steering Group and industry stakeholders meeting - Oct 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 09:00 (CEST) to 25 October 2024, 11:00 (CEST)
Submission of Manufacturers, Manufacturing Business Operations (MBOs) and structured pack size data to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025 to 20 February 2025
Third listen-and-learn focus group meeting of the Quality Innovation Group, European Medicines Agency, Amsterdam, the Netherlands, from 4 June 2024 to 5 June 2024
Third Listen and Learn Focus Group (LLFG) meeting of the Quality Innovation Group (QIG), European Medicines Agency, Amsterdam, the Netherlands, from 4 June 2024 to 5 June 2024
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - February, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2025 to 20 February 2025
Paediatric Committee (PDCO): 12-15 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 November 2024 to 15 November 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 30 June 2025 to 4 July 2025
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 2 June 2025 to 6 June 2025
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 31 March 2025 to 4 April 2025
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 24 February 2025 to 28 February 2025
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 27 January 2025 to 31 January 2025
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2024, 12:30 (CET) to 19 November 2024, 14:30 (CET)
Quarterly system demo - Q4 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 December 2024, 09:00 (CET) to 12 December 2024, 12:15 (CET)
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 6 November 2024, 10:00 (CET) to 6 November 2024, 13:30 (CET)
Committee for Advanced Therapies (CAT): 6-8 November 2024, European Medicines Agency, Amsterdam, the Netherlands, from 6 November 2024 to 8 November 2024
19th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 November 2024, 09:30 (CET) to 15 November 2024, 13:30 (CET)
EMA risk management information day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 13:30 (CET) to 21 November 2024, 17:30 (CET)
Fourth listen-and-learn focus group meeting of the Quality Innovation Group, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2024 to 20 November 2024
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 12:00 (CEST)
SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 January 2025, 10:00 (CET) to 22 January 2025, 12:00 (CET)
Advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
Linkedin Live session: A call to action against antimicrobial resistance , European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 11 November 2024, 11:30 (CET) to 11 November 2024, 12:30 (CET)
Small and medium-sized enterprises info day, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 October 2024, 09:30 (CEST) to 18 October 2024, 16:15 (CEST)
Workshop with Notified Bodies on the Mandatory Scope of the CECP and PECP, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024
Human variation electronic application form (eAF) training session and Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 November 2024, 10:00 (CET) to 8 November 2024, 11:00 (CET)
Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2026 to 26 November 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 26 October 2026 to 29 October 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 28 September - 1 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 28 September 2026 to 1 October 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August - 3 September 2026, European Medicines Agency, Amsterdam, the Netherlands, from 31 August 2026 to 3 September 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 3 - 6 August 2026, European Medicines Agency, Amsterdam, the Netherlands, from 3 August 2026 to 6 August 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 6 - 9 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 9 July 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026 to 12 March 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 February 2026 to 12 February 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026
SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2024, 10:00 (CEST) to 14 October 2024, 12:00 (CEST)
Clinical Data Publication (Policy 0070) webinar - Step 2, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 November 2024, 15:00 (CET) to 14 November 2024, 16:00 (CET)
Pharmacovigilance Risk Assessment Committee (PRAC): 24 - 27 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 24 November 2025 to 27 November 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 27 - 30 October 2025, European Medicines Agency, Amsterdam, the Netherlands, from 27 October 2025 to 30 October 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 29 September - 2 October 2025, European Medicines Agency, Amsterdam, the Netherlands, from 29 September 2025 to 2 October 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 1 - 4 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 1 September 2025 to 4 September 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 August 2025, European Medicines Agency, Amsterdam, the Netherlands, from 4 August 2025 to 7 August 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 July 2025 to 10 July 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 5 - 8 May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 May 2025 to 8 May 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 March 2025 to 13 March 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 13 - 16 January 2025, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2025 to 16 January 2025
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, 20 November 2024
Conversations on Cancer - Pediatric Cancers: Navigating the Challenges Together, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2024, 09:30 (CET) to 19 November 2024, 10:30 (CET)
Thirteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 09:00 (CET) to 22 November 2024, 14:00 (CET)
European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)
European Shortages Monitoring Platform training session on routine shortage reporting for marketing authorisation holders of CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)
Training webinar on post-authorisation procedure management in IRIS for Marketing Authorisation Holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 November 2024, 10:00 (CET) to 12 November 2024, 11:30 (CET)
Conversations on Cancer: Transforming patient lives by therapeutic and regulatory innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)
Conversations On Cancer presents “Living with metastatic breast cancer”, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 October 2023, 15:30 (CEST) to 19 October 2023, 17:00 (CEST)
Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)
Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)
Q&A clinic Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 10:00 (CEST) to 25 October 2024, 10:30 (CEST)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 5 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2024, 10:00 (CET) to 5 November 2024, 10:30 (CET)
Q&A Clinic on Product Management Service (PMS) Product UI & API (3), Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 10:00 (CET) to 22 November 2024, 10:30 (CET)
ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 October 2024, 09:30 (CEST) to 22 October 2024, 17:00 (CEST)
HMA/EMA multi-stakeholder workshop on artificial intelligence (AI) - enabling the safe and responsible use of AI, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 5 November 2024
SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD) for Sponsors, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 11 October 2024, 10:00 (CEST) to 11 October 2024, 12:00 (CEST)
A combination of production-related measures and healthier, more plant-based diet can help tackle EU’s vulnerability related to high-protein feed and benefit the environment.
Multistakeholder workshop on shortages of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2024, 12:30 (CEST) to 1 July 2024, 18:30 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Service (OMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 October 2024, 10:00 (CEST) to 9 October 2024, 12:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Substance Management Service (SMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 October 2024, 10:00 (CEST) to 8 October 2024, 12:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Service (RMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2024, 10:00 (CEST) to 7 October 2024, 12:00 (CEST)
Tenth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 09:00 (CEST) to 26 September 2024, 13:25 (CEST)
Training session on Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 October 2024, 10:00 (CEST) to 17 October 2024, 11:30 (CEST)
Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2024, 09:00 (CEST) to 24 September 2024, 17:00 (CEST)
Second European Medicines Agency (EMA) and IPFA - PPTA global bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 12 November 2024
Fifth EMA/HMA Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 November 2024, 09:00 (CET) to 28 November 2024, 17:00 (CET)
Fourth veterinary big data stakeholder forum, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 October 2024, 10:00 (CEST) to 14 October 2024, 15:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 October 2024, 10:00 (CEST) to 4 October 2024, 12:00 (CEST)
Committee for Orphan Medicinal Products (COMP): 16-18 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 July 2024 to 18 July 2024
New fee regulation: webinar for industry stakeholders (human), Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 October 2024, 10:30 (CEST) to 24 October 2024, 11:30 (CEST)
Clinical Trials Information System (CTIS) bitesize talk: End of transition period and notifications including serious breach, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 October 2024, 15:30 (CEST) to 16 October 2024, 17:00 (CEST)
Information session on the pilot for expert panels' advice for orphan medical devices, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 14:00 (CEST) to 23 September 2024, 16:30 (CEST)
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)
EMA Account Management, what's new?, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 September 2024, 10:00 (CEST) to 20 September 2024, 11:00 (CEST)
Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)
Joint HMA/EMA multi-stakeholder workshop on submission predictability, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 September 2024, 09:00 (CEST) to 25 September 2024, 13:30 (CEST)
Committee for Herbal Medicinal Products (HMPC): 23-25 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024 to 25 September 2024
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 22 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2024, 10:00 (CEST) to 22 October 2024, 10:30 (CEST)